A detailed history of Bank Of Montreal transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 64,198 shares of ITCI stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,198
Previous 292,975 78.09%
Holding current value
$5.36 Million
Previous $20.1 Million 76.61%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$67.99 - $80.84 $15.6 Million - $18.5 Million
-228,777 Reduced 78.09%
64,198 $4.69 Million
Q2 2024

Aug 14, 2024

SELL
$64.76 - $79.84 $2.62 Million - $3.23 Million
-40,480 Reduced 12.14%
292,975 $20.1 Million
Q1 2024

May 13, 2024

SELL
$64.37 - $75.65 $80,913 - $95,092
-1,257 Reduced 0.38%
333,455 $23.1 Million
Q4 2023

Feb 08, 2024

SELL
$46.37 - $73.65 $5.53 Million - $8.78 Million
-119,171 Reduced 26.26%
334,712 $24 Million
Q3 2023

Nov 01, 2023

SELL
$52.09 - $64.1 $232,842 - $286,527
-4,470 Reduced 0.98%
453,883 $23.6 Million
Q2 2023

Aug 02, 2023

SELL
$54.67 - $66.44 $161,112 - $195,798
-2,947 Reduced 0.64%
458,353 $29 Million
Q1 2023

Jun 13, 2024

BUY
$43.8 - $56.99 $5.64 Million - $7.34 Million
128,807 Added 38.63%
462,262 $25 Million
Q4 2022

Feb 01, 2023

SELL
$44.07 - $54.45 $18,994 - $23,467
-431 Reduced 0.09%
461,300 $24.4 Million
Q3 2022

Nov 10, 2022

BUY
$42.7 - $59.99 $45,347 - $63,709
1,062 Added 0.23%
461,731 $21.6 Million
Q2 2022

Aug 11, 2022

SELL
$43.0 - $65.64 $289,304 - $441,625
-6,728 Reduced 1.44%
460,669 $26.8 Million
Q1 2022

May 12, 2022

BUY
$38.74 - $62.09 $6.91 Million - $11.1 Million
178,420 Added 61.74%
467,397 $28.3 Million
Q4 2021

Feb 11, 2022

BUY
$35.2 - $53.42 $9,609 - $14,583
273 Added 0.09%
288,977 $15.4 Million
Q3 2021

Nov 12, 2021

SELL
$28.72 - $42.49 $4,164 - $6,161
-145 Reduced 0.05%
288,704 $10.8 Million
Q2 2021

Aug 12, 2021

BUY
$29.3 - $44.5 $8.46 Million - $12.9 Million
288,849 New
288,849 $11.6 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.